BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2752911)

  • 1. In vitro bactericidal activity and post-antibiotic effect of dactimicin, a new aminoglycoside, alone and in combination with other antibiotics.
    Debbia EA; Schito GC; Stefani S; Nicoletti G
    Drugs Exp Clin Res; 1989; 15(3):125-8. PubMed ID: 2752911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.
    Paglia P; Molinari G; Pesce A; Debbia EA
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):639-43. PubMed ID: 2506028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First microbiological approach to dactimicin, a novel aminoglycoside antibiotic.
    Stefani S; Nicoletti G; Russo G; Toscano MA
    Drugs Exp Clin Res; 1987; 13(12):727-9. PubMed ID: 3447875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria.
    Stefani S; Debbia EA; Schito GC; Russo G
    Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
    Inouye S; Hara T; Matsuhashi Y; Kitasato I
    Drugs Exp Clin Res; 1989; 15(10):455-63. PubMed ID: 2632214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity and post-antibiotic effect in vitro of dactimicin alone and in combination with other drugs.
    Debbia E; Schito GC; Stefani S; Nicoletti G
    J Chemother; 1989 Jul; 1(4 Suppl):187-8. PubMed ID: 16312361
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci.
    Stefani S; Mezzatesta M; Oliveri S; Nicolosi VM; Russo G
    Chemioterapia; 1987 Aug; 6(4):264-8. PubMed ID: 3652276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-antibiotic effect induced by an antibiotic combination: influence of altered susceptibility to individual components.
    Li RC; Tang MC
    J Antimicrob Chemother; 2005 Apr; 55(4):583-6. PubMed ID: 15728143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria.
    Omoto S; Yoshida T; Kurebe M; Inouye S
    Drugs Exp Clin Res; 1987; 13(12):719-25. PubMed ID: 3447874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E; Schito GC; Nicoletti G; Speciale A
    Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of clinical isolates to dactimicin and gentamicin.
    Bergan T
    Drugs Exp Clin Res; 1989; 15(3):109-12. PubMed ID: 2752907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria.
    Lavigne JP; Bonnet R; Michaux-Charachon S; Jourdan J; Caillon J; Sotto A
    J Antimicrob Chemother; 2004 Apr; 53(4):616-9. PubMed ID: 14985275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.
    Gu JW; Neu HC
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1998-2003. PubMed ID: 2514625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
    Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A
    J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
    Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
    Scand J Infect Dis Suppl; 1990; 74():129-32. PubMed ID: 2129064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.